GIVLAARI Alnylam Australia Pty Ltd
Product name
GIVLAARI
Sponsor
Accepted date
Jan-2023
Active ingredients
givosiran sodium
Proposed indication
For the treatment of acute hepatic porphyria.
Application type
A (new medicine)
Publication date
Jan-23
Registration process
Orphan drug
Sponsors receive a fee waiver to help bring medicines for a small population to market.